Olmesartan Medoxomil Tablet
Product Images NDC 33342-180

8 FDA label images from Macleods Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 33342-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olme 20mg 30's (Olmesartan Medoxomil 20mg 30 Tablet)

Olme 20mg 30's (Olmesartan Medoxomil 20mg 30 Tablet)
Label for Olmesartan medoxomil Tablets 20 mg, oral tablet form, manufactured by Macleods Pharmaceuticals Limited. The label indicates the product contains 30 tablets and provides storage instructions. It shows Macleods Pharma USA as the distributor in Plainsboro, NJ, and the manufacturing location in Baddi, Himachal Pradesh, India.*
FDA Label Image

Olme 20mg 90's (Olmesartan Medoxomil 20mg 90 Tablet)

Olme 20mg 90's (Olmesartan Medoxomil 20mg 90 Tablet)
Label for Olmesartan Medoxomil Tablets 20 mg, oral tablet form. The label shows the product name, strength (20 mg), and quantity of 90 tablets. It is manufactured for Macleods Pharma USA, Inc., Plainsboro, NJ, and by Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India. Storage instructions and barcode are also present.*
FDA Label Image

Olme 40mg 30's (Olmesartan Medoxomil 40mg 30 Tablet)

Olme 40mg 30's (Olmesartan Medoxomil 40mg 30 Tablet)
Label for Olmesartan Medoxomil Tablets, 40 mg strength, oral tablet form. The label shows the active ingredient Olmesartan medoxomil USP 40 mg per tablet, packaged in a bottle containing 30 tablets. It is manufactured for Macleods Pharma USA, Inc. and by Macleods Pharmaceuticals Ltd. in India. Storage instructions and barcode are also visible on the label.*
FDA Label Image

Olme 40mg 90's (Olmesartan Medoxomil 40mg 90 Tablet)

Olme 40mg 90's (Olmesartan Medoxomil 40mg 90 Tablet)
Label for Olmesartan Medoxomil Tablets 40 mg in a package of 90 tablets. The label shows the active ingredient Olmesartan medoxomil, USP 40 mg per tablet. It is manufactured by Macleods Pharmaceuticals Ltd., India, and labeled for Macleods Pharma USA, Inc. Storage instructions recommend 20° to 25°C with permitted excursions. Barcodes and a product code are also visible.*
FDA Label Image

Olme 5mg 30's (Olmesartan Medoxomil 5mg 30 Tablet)

Olme 5mg 30's (Olmesartan Medoxomil 5mg 30 Tablet)
Label for Olmesartan Medoxomil Tablets 5 mg by Macleods Pharmaceuticals Limited. The label states each tablet contains 5 mg Olmesartan medoxomil, USP. It includes storage instructions and manufacturer details with package count of 30 tablets. The label features two barcodes and branding for Macleods Pharma USA and Macleods Pharmaceuticals Ltd, India.*
FDA Label Image

Olme 5mg 90's (Olmesartan Medoxomil 5mg 90 Tablet)

Olme 5mg 90's (Olmesartan Medoxomil 5mg 90 Tablet)
Label for Olmesartan Medoxomil Tablets 5 mg, oral tablets, manufactured for Macleods Pharma USA, Inc. and by Macleods Pharmaceuticals Ltd., India. The label shows 90 tablets per container and includes storage instructions. It prominently displays the 5 mg strength and the product name with barcodes on both sides.*
FDA Label Image

Figure (Olmesartan Medoxomil Figure)

Figure (Olmesartan Medoxomil Figure)
A dose-response chart illustrating the placebo-adjusted reduction in blood pressure (mmHg) with varying doses of Olmesartan Medoxomil in mg. The graph shows two lines representing systolic and diastolic blood pressure reductions, with systolic BP reduction higher across doses compared to diastolic BP.*
FDA Label Image

Olmesartan Medoxomil Structure (Str)

Olmesartan Medoxomil Structure (Str)
Chemical structure of olmesartan medoxomil, showing its molecular arrangement with specific functional groups and ring structures characteristic of this antihypertensive agent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.